A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

CompletedOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Healthy
Interventions
DRUG

Ritalin

1 - 20 mg tablet taken once on Day 0 and taken once on Day 28

DRUG

Placebo

1 - matching tablet taken once on Day 0 and once on Day 28

DRUG

Ritalin

1 - 20 mg tablet taken once on Day 0 and taken once on Day 28

DRUG

Placebo

1 - matching tablet taken once on Day 0 and once on Day 28

Trial Locations (4)

33024

Broward Research Group, Hollywood

33143

Miami Research Associates, South Miami

49007

Jasper Clinic, Inc., Kalamazoo

90806

Collaborative Neuroscience Network, LLC, Long Beach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02265718 - A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers | Biotech Hunter | Biotech Hunter